Pan-European Short Selling Regulation – the Implications for US Market Participants
Total Page:16
File Type:pdf, Size:1020Kb
Number 1418 October 15, 2012 Client Alert Latham & Watkins Corporate Department Update: Pan-European Short Selling Regulation – The Implications for US Market Participants Overview This edition1 of our update on the pan-European short selling Regulation2 focuses on the implications of the Regulation for market participants in the United States (US). In particular, we focus on market participants whose trading activities are conducted in the US in financial instruments that have a nexus with the European In this Client Union (EU), such as a parallel EU listing of a financial instrument or an EU listing of “ the underlying financial instrument. Such activities, which may subject the market Alert we discuss participant not only to the US short selling regime, but also to the Regulation,3 the application of include short sales of (i) certain American Depositary Receipts (ADRs) of EU-listed the Regulation to issuers, and (ii) dual listed securities of issuers that are concurrently listed on one of the EU and US trading venues. ADRs and dual- The Regulation applies only to those financial instruments (i) that are admitted listed securities to trading on a trading venue in the EU, and (ii) whose principal trading venue that are traded (defined below) is determined to be in the EU. The Regulation applies regardless in the US, and of whether the financial instrument is traded on or off-exchange (i.e., over-the- counter). The Regulation defines “financial instrument” broadly4 and includes all compare certain of transferable securities and derivative contracts relating to securities that are traded the key concepts on an EU trading venue.5 and definitions In this Client Alert, we discuss the application of some of the key provisions of the in the Regulation Regulation as they relate to (i) ADRs, and (ii) dual-listed securities that are traded in the US. We have also compared certain fundamental concepts and definitions with those in the Regulation with those found in the US regulatory regime in Regulation found in the US SHO (Reg SHO)6 under the US Securities Exchange Act of 1934, as amended (the regulatory regime Exchange Act). in Regulation Application of Articles 3, 5 and 12 of the Regulation to ADRs SHO.” and Dual-Listed Securities Traded in the US The Regulation’s definition of a “financial instrument” includes all transferable securities. Transferable securities, in turn, are defined as those classes of securities which are negotiable on the capital markets (with the exception of instruments of payment), such as shares in companies, partnerships or other entities, as well as Latham & Watkins operates worldwide as a limited liability partnership organized under the laws of the State of Delaware (USA) with affiliated limited liability partnerships conducting the practice in the United Kingdom, France, Italy and Singapore and as affiliated partnerships conducting the practice in Hong Kong and Japan. Latham & Watkins practices in Saudi Arabia in association with the Law Office of Salman M. Al-Sudairi. In Qatar, Latham & Watkins LLP is licensed by the Qatar Financial Centre Authority. Under New York’s Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding our conduct under New York’s Disciplinary Rules to Latham & Watkins LLP, 885 Third Avenue, New York, NY 10022-4834, Phone: +1.212.906.1200. © Copyright 2012 Latham & Watkins. All Rights Reserved. Latham & Watkins | Client Alert depositary receipts in respect of shares, bonds or other forms of securitized debt, including depositary receipts in respect of such securities, and any other securities giving the right to acquire or sell any such transferable securities.7 Central to the Regulation is the concept of the “principal trading venue” for a financial instrument. This is determined based on the trading volume for the financial instrument on the relevant trading venues,8 calculated in accordance with the provisions of the Delegated Regulation.9 The Regulation requires the European Securities and Markets Authority (ESMA) to publish a list of shares whose principal trading venue is determined to be outside the EU (List of Exempted Shares).10 Thus, shares included on the List of Exempted Shares will not be subject to the Regulation when it becomes applicable on November 1, 2012.11 There are currently 10,087 issuers included on the List of Exempted Shares published on October 4, 2012.12 We understand that this List of Exempted Shares is a consolidation of the information provided by Member State competent authorities to ESMA.13 Each Member State competent authority was required to compile a list of shares admitted to trading in its respective jurisdiction, whose principal trading venue the competent authority determined to be located outside the EU. In compiling and providing their respective lists of exempted shares, it appears that several competent authorities included ADRs.14 ADRs We have compared the List of Exempted Shares to a list of European issuers that have ADRs admitted to trading in the US, based on their International Securities Identification Number (ISIN). There are currently over a thousand European issuers listed on one or more of the EU trading venues whose ADRs are admitted to trading on either the New York Stock Exchange, NASDAQ or the American Stock Exchange. Our comparison of the two lists reflects at least 78 common issuers whose shares would be exempt from the Regulation. Article 3 of the Regulation prescribes the manner in which short, net short and long positions are to be calculated, in respect of both “shares” and “financial instruments” other than shares. Article 5 of the Regulation addresses the transparency or reporting requirements, including the private and public notification thresholds further described in “Transparency Obligations” (below), in respect of net short positions in relation to the issued share capital of a company that has shares admitted to trading on an EU trading venue. The Delegated Regulation provides guidance on “in relation to” and states that a holding of shares, or any exposure through a financial instrument other than a share which confers a financial advantage in the event of an increase or decrease in the price or value of the share, must be taken into account when calculating the short and net short position in a relevant financial instrument.15 The financial instruments to be considered include options, futures, covered warrants, contracts for difference, units in ETFs, complex derivatives and global depositary receipts.16 The inclusion of global depositary receipts within the list of financial instruments that should be considered in calculating a short position suggests, by analogy, that ADRs may also be included in such calculations. Based on the analysis above and the information provided by ESMA at this time, it thus appears possible that the ADRs that are not included in the List of Exempted Shares17 will be subject to the reporting obligations under the Regulation. We have included details in respect of the reporting obligations in the section on “Transparency Obligations” (below). 2 Number 1418 | October 15, 2012 Latham & Watkins | Client Alert In contrast to the language of Articles 3 and 5 of the Regulation, Article 12, which addresses uncovered short sales and in particular restricts “uncovered short sales in shares,” makes no corresponding reference to financial instruments. Instead, the provisions of Article 12 appear to be limited to shares. We note that the List of Exempted Shares is not limited to “shares” whose principal trading venue is outside the EU, as a number of Member State competent authorities have also included ADRs. This suggests that at least some Member State competent authorities might view shares and ADRs as essentially fungible for these purposes. If this were the case, ADRs would also be subject to the Regulation’s ban on uncovered short sales. In the absence of clarification from ESMA, we believe it cannot be ruled out that ESMA might take the position that the ban on naked short sales also applies to ADRs. Dual-Listed Securities We have also compared the List of Exempted Shares with a list of EU issuers whose ordinary shares are concurrently admitted to trading on an EU trading venue and on one of the New York Stock Exchange, NASDAQ or the American Stock Exchange, on a name-by-name basis (as a comparison on an ISIN basis was not possible). Our comparison of the two lists identifies at least 31 issuers in common. Based on our understanding of the Regulation and absent further clarification from ESMA, we believe that US short selling activity in the shares of the remaining issuers admitted to trading in the US, but not included in the List of Exempted Shares, will be subject to the transparency requirements and the prohibition on naked short sales under the Regulation. Analysis of Certain Key Concepts and Definitions of Reg SHO and the Regulation Both the Regulation and Reg SHO seek to eliminate abusive short selling while preserving the ability to engage in legitimate short sales. However, as further described below, the EU and US regulatory regimes differ in the scope of activities and financial instruments subject to regulation and the availability of exemptions. Perhaps most significantly, the Regulation and Reg SHO place the obligation to locate the security sold short on different market participants. Under Reg SHO, the broker-dealer has to perform the locate. Under the Regulation, the locate obligation falls on the short seller. The discussion below focuses on (A) the definitions of “short sale” and “ownership,” (B) the “locate” requirement, including the treatment of naked short sales, and (C) net short positions. For each of these topics, we briefly compare the treatment of these matters under each of the EU and the US regulatory regimes.